Table 1.
Baselinea characteristics and major clinical parameters
| Characteristic | TOT = 155 |
|---|---|
| N (%) | |
| Sex | |
| Female | 77 (49.7%) |
| Male | 78 (50.3%) |
| Age | |
| Median (range) | 66 (28–85) |
| Age | |
| >70 | 55 (35.5%) |
| ≤70 | 100 (64.5%) |
| Baseline ECOG PS | |
| 0 | 112 (72.2%) |
| 1 | 37 (23.9%) |
| ≥2 | 6 (3.9%) |
| Primary tumour resected | |
| Yes | 135 (87.1%) |
| No | 20 (12.9%) |
| Primary tumour location | |
| Right | 115 (74.2%) |
| Left | 31 (20.0%) |
| Rectal | 9 (6.8%) |
| Presentation of metastases | |
| Synchronous | 102 (65.8%) |
| Metachronous | 53 (34.2%) |
| Number of metastatic sites | |
| Single | 97 (63%) |
| Multiple | 57 (37%) |
| Missing | 1 |
| Sites of metastases at diagnosis | |
| Liver | 82 (53%) |
| Lung | 27 (17.4%) |
| Distant nodes | 59 (38%) |
| Other | 28 (18.1%) |
| Missing | 1 |
ai.e. at the time of first-line treatment start or, for candidates to BSC only, at the first visit for metastatic disease